Frontiers in Genetics (Aug 2021)

The Effect of ACTN3 and VDR Polymorphisms on Skeletal Muscle Performance in Axial Spondyloarthropathies

  • Isabel Pimenta,
  • Isabel Pimenta,
  • Hugo Mateus,
  • Hugo Mateus,
  • Santiago Rodrigues-Manica,
  • Santiago Rodrigues-Manica,
  • Rita Pinheiro-Torres,
  • Rita Pinheiro-Torres,
  • Agna Neto,
  • Agna Neto,
  • Lúcia Domingues,
  • Lúcia Domingues,
  • Carolina Lage Crespo,
  • Atlas Sardoo,
  • Atlas Sardoo,
  • Pedro Machado,
  • Jaime C. Branco,
  • Jaime C. Branco,
  • Susana N. Silva,
  • Fernando M. Pimentel-Santos,
  • Fernando M. Pimentel-Santos

DOI
https://doi.org/10.3389/fgene.2021.688984
Journal volume & issue
Vol. 12

Abstract

Read online

BackgroundSpondyloarthritis (SpA) are the most common group of chronic inflammatory rheumatic diseases affecting about 1.5% of the adult Caucasian population. Low back pain is the most common symptom. The aetiopathogenesis of SpA is multifactorial, with well-known genetic and environmental contributions. Furthermore, muscle properties might also be involved in the pathophysiological process and these could be modulated by the genetic background. Alpha-actinin-3 (ACTN3) and Vitamin D receptor (VDR) genes are well-known genes related with muscle performance. Our aim was to analyze four SNPs of these genes and to evaluate their influence in axial SpA (axSpA) susceptibility, phenotype and muscle properties.MethodsWe performed a pilot study based on case-control approach involving 56 participants: 28 axSpA patients and 28 healthy controls matched by age, gender and levels of physical activity. Clinical, epidemiological and muscle characterization data—muscle physical properties (stiffness, tone, and elasticity), strength, mass, and performance, were collected. Two different muscles were considered for analysis, the Multifidus and Gastrocnemius. Four SNPs of ACTN3 (rs1815739) and VDR (rs2228570, rs731236, and rs7975232), were selected, analyzed and correlated with clinical, epidemiological and muscle characterization data.ResultsIn total, 51 individuals (27 axSpA patients and 24 matched controls) were eligible for further genetic analysis, 66.7% being male and with a mean age of 36 years. Muscle physical properties, muscle strength and muscle mass were similar in both groups; however, axSpA patients showed a decrease in muscle performance. None of the studied SNPs were associated with disease susceptibility/phenotype, muscle physical properties, muscle strength or muscle mass. However, ACTN3 rs1815739 and VDR rs2228570 were shown to be associated with muscle performance.ConclusionOur results suggest an association between ACTN3 and VDR polymorphisms and muscle performance in axSpA.

Keywords